Clinical Trial

Phase IIT Trial of SNA009

Name: Phase IIT Trial of SNA009 — clinical trial record (NCT07597759)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Early Phase 1

View on ClinicalTrials.gov →

Summary

This clinical trial is a single-center, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics and radiation dosimetry of 68Ga-NODAGA-SNA009 in patients with colorectal cancer.

Trial Details

NCT Number	NCT07597759
Lead Sponsor	SmartNuclide Biopharma Collaborators: Tianjin Medical University Cancer Institute and Hospital
Conditions	Colorectal Cancer, GPA33
Enrollment	12 participants
Start Date	2025-10-30
Primary Completion	2025-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-19